Skip to main content

Advertisement

Log in

Subcutaneous self-infusions of immunoglobulins as a potential therapeutic regimen in immune-mediated neuropathies

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP (2004) Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30:131–156

    Article  CAS  PubMed  Google Scholar 

  2. Köller H, Kieseier BC, Jander S, Hartung HP (2005) Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 352:1343–1356

    Article  PubMed  Google Scholar 

  3. Stangel M, Hartung HP, Marx P, Gold R (1998) Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci 153:203–214

    Article  CAS  PubMed  Google Scholar 

  4. Toyka KV, Gold R (2003) The pathogenesis of CIDP: rationale for treatment with immunomodulatory agents. Neurology 60:S2–7

    Article  CAS  PubMed  Google Scholar 

  5. Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291:2367–2375

    Article  CAS  PubMed  Google Scholar 

  6. Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorkander J (2000) The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol 20:94–100

    Article  CAS  PubMed  Google Scholar 

  7. Gardulf A, Hammarstrom L, Smith CI (1991) Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 338:162–166

    Article  CAS  PubMed  Google Scholar 

  8. Nicolay U, Kiessling P, Berger M, Gupta S, Yel L, Roifman CM, Gardulf A, Eichmann F, Haag S, Massion C, Ochs HD (2006) Health-related quality of life and treatment satisfaction in north american patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home. J Clin Immunol 26:65–72

    Article  CAS  PubMed  Google Scholar 

  9. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force (1991) Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41:617–618

    Google Scholar 

  10. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA (2002) Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 72:596–601

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernd C. Kieseier.

Additional information

Received in revised form: 16 March 2006

Rights and permissions

Reprints and permissions

About this article

Cite this article

Köller, H., Schroeter, M., Feischen, H. et al. Subcutaneous self-infusions of immunoglobulins as a potential therapeutic regimen in immune-mediated neuropathies. J Neurol 253, 1505–1506 (2006). https://doi.org/10.1007/s00415-006-0258-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0258-0

Keywords

Navigation